NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte (VCYT) Rises 10.4% After Lifting 2025 Revenue Outlook and Reporting Strong Q2 Sales

Earlier this month, Veracyte announced its second quarter 2025 results, with revenue rising to US$130.16 million from US$114.43 million a year earlier, but swinging from net income to a small net loss; the company also raised its revenue guidance for the full year to a new range of US$496 million to US$504 million and increased its expected testing revenue growth. The updated guidance, alongside strong first-half revenue figures, underscores management's increased confidence in higher demand...
NYSE:SBH
NYSE:SBHSpecialty Retail

Is Sally Beauty’s (SBH) Share Buyback Strategy Reflecting a Shift in Long-Term Growth Priorities?

On August 5, 2025, Sally Beauty Holdings reported third quarter results showing an increase in net income to US$45.72 million and higher earnings per share, despite a slight year-over-year decline in sales, updated its full year guidance to expect flat comparable sales, and announced continued progress in its multi-year share buyback program. An interesting insight is that consolidated net sales are projected to be about 75 basis points lower than comparable sales for the year, reflecting...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

How Expanded NCCN Guidelines for FIRDAPSE Have Changed the Investment Story at Catalyst Pharmaceuticals (CPRX)

Earlier this month, Catalyst Pharmaceuticals reported strong second quarter results, reaffirmed its full-year 2025 revenue guidance of US$545 million to US$565 million, and highlighted that new NCCN guidelines now include its lead product, FIRDAPSE, for Lambert Eaton myasthenic syndrome associated with small cell lung cancer. This guideline update may significantly expand the recognized patient population for FIRDAPSE, potentially increasing diagnosis rates and strengthening Catalyst’s...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Will Vera Therapeutics' (VERA) Major Equity Raise Reshape Its Resilience Amid Mounting Losses?

Vera Therapeutics recently reported a second quarter net loss of US$76.53 million, significantly higher than a year ago, and announced a US$200 million follow-on equity offering of Class A common stock. The concurrent disclosure of increased quarterly losses and a major capital raise highlights potential funding needs and ongoing operational pressures facing the company. We’ll examine how Vera Therapeutics’ expanded capital raise shapes its investment narrative amid growing financial...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Credo Technology Group Holding (CRDO) Settles Patent Dispute With Amphenol Ending Legal Battles

Credo Technology Group Holding (CRDO) recently secured a significant 95% price increase over the last quarter, coinciding with its settlement agreement with Amphenol that ended patent disputes on electrical cable technology. This favorable legal development likely added a sense of stability and confidence among investors. Parallelly, the company announced robust earnings, showing major revenue and net income improvements, which may have been instrumental in driving this rally. Meanwhile, the...
NasdaqCM:BTBT
NasdaqCM:BTBTSoftware

Bit Digital (BTBT) Reports US$7M Sales Drop But Turns US$15M Profit

Bit Digital (BTBT) recently reported a significant 34% increase in share price over the last quarter, possibly influenced by key events such as its earnings announcement. The company noted a turnaround in net income to $14.87 million for the second quarter, a stark contrast from the previous year's losses. Although the broader market experienced a general upswing, Bit Digital's performance may have been impacted by its follow-on equity offerings and executive changes. Overall, while the...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

TMC the metals (TMC) Reports Higher Net Loss For Q2 2025

TMC the metals (TMC) announced a Q2 net loss of $74 million, a significant increase from the $20 million loss in Q2 2024, with losses per share also seeing a sharp rise. Despite these financial challenges, the company's share price rose by 49% over the last quarter, a move that stands out against a flat broader market. Contributing factors may include TMC's private placements with Korea Zinc, providing a potential financing boost, and new board appointments that could signal strategic shifts...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta (OKTA) Expands Board With Industry Veterans Schellhase And Wilderotter

Okta (OKTA) recently expanded its Board of Directors, adding experienced leaders to improve its governance with two new appointments, David Schellhase and Mary Agnes Wilderotter. Despite these changes, the company's share price declined 3% over the last month. Meanwhile, the market overall has shown positive momentum with significant gains, particularly seen in the Dow hitting a record high. The board changes at Okta might have lent some stability during this period, but broader market...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group (LCID) Unveils Adventurous Lucid Gravity X SUV With Off-Road Ready Design

Last week, Lucid Group (LCID) unveiled the Lucid Gravity X Concept SUV at Monterey Car Week, highlighting its focus on innovative electric vehicles with adventure-ready capabilities. This announcement coincided with a notable 3.69% price increase for the company's stock. While the unveiling possibly contributed to Lucid's upward movement, broader market trends were also influential. Over the same period, the Dow Jones reached a record high while the S&P 500 and Nasdaq saw mixed performances,...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) Co-Founders Exit Board as Sean Aggarwal Takes Charge

Lyft (LYFT) recently announced significant executive changes, with co-founders Logan Green and John Zimmer stepping down from the Board of Directors, a move that could have implications for board independence under new Chair Sean Aggarwal. This shift coincides with Lyft's share price gaining 2.89% over the past week, aligning with broader market trends where the Dow Jones reached record highs, though the S&P 500 and Nasdaq saw slight declines. These executive moves at Lyft add weight to the...
NasdaqCM:QUBT
NasdaqCM:QUBTTech

Quantum Computing (QUBT): Sales Decline With US$36 Million Net Loss in Earnings Report

Quantum Computing (QUBT) announced considerable second-quarter financial setbacks, with sales dropping by 67% year-over-year and a net loss widening significantly. However, during the period, the company also marked important milestones, including securing a contract with the National Institute of Standards and Technology and shipping its first commercial entangled photon source. These developments coincided with a period where the Dow hit record highs, although the S&P 500 and Nasdaq...